SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-24-041509
Filing Date
2024-02-21
Accepted
2024-02-21 16:30:39
Documents
1
Group Members
ESHELMAN VENTURES, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d795034dsc13da.htm SC 13D/A 48104
  Complete submission text file 0001193125-24-041509.txt   49634
Mailing Address PPD INC 929 NORTH FRONT STREET WILMINGTON NC 28401
Business Address
ESHELMAN FREDRIC N (Filed by) CIK: 0001033409 (see all company filings)

Type: SC 13D/A

Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Subject) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90214 | Film No.: 24660105
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)